BKBadr Khbouz

Badr Khbouz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Badr Khbouz has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • François Jouret

    Division of Nephrology, Department of Internal Medicine, University of Liège Hospital, Liège, Belgium

    3 shared publications
  • Agnès Noël

    Groupe Interdisciplinaire de Génoprotéomique Appliquée, Cancer Sciences, University of Liège, Liège, Belgium

    1 shared publication
  • Arianna Cirillo

    Center for Interdisciplinary Research on Medicines, Metabolomics Group, University of Liège, Liège, Belgium

    1 shared publication
  • David Legouis

    Laboratory of renal cells, Department of physiology and cell metabolism, University of Geneva, 1205 Geneva, Switzerland; Division of intensive care medicine, Department of acute care medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of anaesthesiology, pharmacology, intensive care and emergency medicine, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland

    1 shared publication
  • Eileen Dahlke

    Institute of Anatomy Christian Albrechts‐University Kiel Germany

    1 shared publication
  • Franziska Theilig

    Institute of Anatomy Christian Albrechts‐University Kiel Germany

    1 shared publication

Latest Publications

  • Open Access

    Radiotherapy Advances in Renal Disease—Focus on Renal Ischemic Preconditioning

    by Badr Khbouz, Shiyang Gu, Tiago Pinto Coelho, François Lallemand, François Jouret

    Ionizing irradiation is widely applied as a fundamental therapeutic treatment in several diseases. Acute kidney injury (AKI) represents a global public health problem with major morbidity and mortality. Renal ischemia/reperfusion (I/R) is the main cause of AKI. I/R injury occurs when blood flow to the kidney is transiently interrupted and then restored. Such an ischemic insult significantly impairs renal function in the short and long terms. Renal ischemic preconditioning (IPC) corresponds to the maneuvers intended to prevent or attenuate the ischemic damage. In murine models, irradiation-induced preconditioning (IP) renders the renal parenchyma resistant to subsequent damage by activating defense pathways involved in oxidative stress, angiogenesis, and inflammation. Before envisioning translational applications in patients, safe irradiation modalities, including timing, dosage, and fractionation, need to be defined.


  • Kidney-targeted irradiation triggers renal ischemic preconditioning in mice

    by Badr Khbouz, François Lallemand, Arianna Cirillo, Pascal Rowart, David Legouis, Nor Eddine Sounni, Agnès Noël, Pascal De Tullio, Sophie de Seigneux, François Jouret

    Renal ischemia-reperfusion (I/R) causes acute kidney injury (AKI). Ischemic preconditioning (IPC) attenuates I/R-associated AKI. Whole body irradiation induces renal IPC in mice. Still, the mechanisms remain largely unknown. Furthermore, the impact of kidney-centered irradiation on renal resistance against I/R has not been studied. Renal irradiation (8.5 Gy) was done in male 8- to 12-wk-old C57bl/6 mice using a small animal radiation therapy device. Left renal I/R was performed by clamping the renal pedicles for 30 min, with simultaneous right nephrectomy, at 7, 14, and 28 days postirradiation. The renal reperfusion lasted 48 h. Following I/R, blood urea nitrogen (BUN) and serum creatinine (SCr) levels were lower in preirradiated mice compared with controls; so was the histological Jablonski score of AKI. The metabolomics signature of renal I/R was attenuated in preirradiated mice. The numbers of proliferating cell nuclear antigen (PCNA)-, cluster of differentiation molecule 11b (CD11b)-, and cell surface glycoprotein F4/80-positive cells in the renal parenchyma post-I/R were reduced in preirradiated versus control groups. Such IPC was significantly observed as early as day 14 postirradiation. RNA sequencing showed an upregulation of angiogenesis- and stress response-related signaling pathways in irradiated nonischemic kidneys on day 28. Qualitative RT-PCR confirmed the increased expression of vascular endothelial growth factor (VEGF), activin receptor-like kinase 5 (ALK5), heme oxygenase-1 (HO1), platelet endothelial cell adhesion molecule-1 (PECAM1), NADPH oxidase 2 (NOX2), and heat shock proteins 70 and 27 (HSP70 and HSP27, respectively) in irradiated kidneys compared with controls. In addition, irradiated kidneys showed an increased CD31-positive vascular area compared with controls. A 14-day gavage of irradiated mice with the antiangiogenic drug sunitinib before I/R abrogated the irradiation-induced IPC at both functional and structural levels. Our observations suggest that kidney-centered irradiation activates proangiogenic pathways and induces IPC, with preserved renal function and attenuated inflammation post-I/R. NEW & NOTEWORTHY This study based on a mouse model of renal ischemia-reperfusion (I/R) aimed to 1) test whether and how irradiation strictly centered on the kidney protects against the I/R injury and 2) determine the shortest efficient delay of kidney irradiation to achieve such nephroprotection. Kidney irradiation increased the vascular surface in the renal parenchyma and conferred resistance against renal I/R damage, which highlights novel putative strategies in the field of ischemic acute kidney injury.


  • The genetic deletion of the Dual Specificity Phosphatase 3 (DUSP3) attenuates kidney damage and inflammation following ischaemia/reperfusion injury in mouse

    by Badr Khbouz, Pascal Rowart, Laurence Poma, Eileen Dahlke, Martina Bottner, Matthew Stokes, Géraldine Bolen, Souad Rahmouni, Franziska Theilig, François Jouret

    Aim: Dual Specificity Phosphatase 3 (DUSP3) regulates the innate immune response, with a putative role in angiogenesis. Modulating inflammation and perfusion contributes to renal conditioning against ischaemia/reperfusion (I/R). We postulate that the functional loss of DUSP3 is associated with kidney resistance to I/R.Methods: Ten C57BL/6 male WT and Dusp3−/− mice underwent right nephrectomy and left renal I/R (30 min/48 hours). Renal injury was assessed based on serum levels of urea (BUN) and Jablonski score. The expression of CD31 and VEGF vascular markers was quantified by RT‐qPCR and immuno‐staining. Renal resistivity index (RRI) was measured in vivo by Doppler ultrasound. Comparative phosphoproteomics was conducted using IMAC enrichment of phosphopeptides. Inflammatory markers were quantified at both mRNA and protein levels in ischaemic vs non‐ischaemic kidneys in WT vs Dusp3−/−.Results: At baseline, we located DUSP3 in renal glomeruli and endothelial cells. CD31‐positive vascular network was significantly larger in Dusp3−/− kidneys compared to WT, with a lower RRI in Dusp3−/− mice. Following I/R, BUN and Jablonski score were significantly lower in Dusp3−/− vs WT mice. Phosphoproteomics highlighted a down‐regulation of inflammatory pathways and up‐regulation of phospho‐sites involved in cell metabolism and VEGF‐related angiogenesis in Dusp3−/− vs WT ischaemic kidneys. Dusp3−/− ischaemic kidneys showed decreased mRNA levels of CD11b, TNF‐α, KIM‐1, IL‐6, IL‐1β and caspase‐3 compared to controls. The numbers of PCNA‐, F4‐80‐ and CD11b‐positive cells were reduced in Dusp3−/− vs WT kidneys post‐I/R.Conclusion: Genetic inactivation of Dusp3 is associated with kidney conditioning against I/R, possibly due to attenuated inflammation and improved perfusion.